课题基金 / 基金详情

Development of a Human Intraepithelial Cancer Model

Development of a Human Intraepithelial Cancer Model
人类上皮内癌模型的开发
批准号:
6337430
负责人:
Paul Barth Conrad
金额:
$9.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-08-01 至 2003-01-31

项目摘要

项目成果

Paul Barth Conrad的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (PROVIDED BY APPLICANT): Over half of all human cancers occur in squamous epithelia. In order to enhance drug discovery for the treatment of squamous cell carcinoma (SCC) and other cancers, it is essential to have an organotypic in vitro model which recapitulates tumor and normal epithelial interactions. The Allen-Hoffmann laboratory recently developed an organotypic model that permits the assessment of tumor growth in stratified human squamous epithelia. The model is a co-culture of genetically marked human SCC cells and unmarked spontaneously immortalized human keratinocytes called NIKS cells. Unlike current in vitro assays, this model accounts for the influence of the normal tissue microenvironment (NTM) on the growth and differentiation of SCC cells. Another advantage is the model's relevance for other epithelial cancers (e.g., cervix, trachea) and its capacity for combination with other treatments (e.g., surgery, radiation). Our strategy for this proposal is to validate and optimize the organotypic co-cultures in the presence of known and novel anticancer agents (e.g., chemotherapeutics, cytostatic drugs) and quantify their effect on malignant cell growth by monitoring the genetically marked SCC cells. Pending completion of this Phase I work, we plan to develop a high-throughput, microliter-volume screening format to identify novel anti-tumor agents using the NIKS-based, human NTM tumor assay. PROPOSED COMMERCIAL APPLICATION: It is essential for effective durg discovery that in vitro models be able to test potential anticancer agents in a physiologically relevant context. Stratatech is developing products and services using a co-cultured system of genetically tagged squamous cell carcinoma (SCC) cells in an organotypic culture comprised of our propietary NIKS cell line. This model system represents a major technological advance for screening drugs or agents of potential use in treating cancers of the stratified squamous epithelia (e.g., head and neck, oral mucosa, cervix, trachea).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineering a Human Organ for Dry Storage
  • 批准号:
    6641852
  • 项目类别:
  • 资助金额:
    $9.98万
  • 财政年份:
    2003
  • 负责人:
    Paul Barth Conrad
  • 依托单位:
Cryopreservation of a Living Human Skin Equivalent
  • 批准号:
    6404181
  • 项目类别:
  • 资助金额:
    $10.14万
  • 财政年份:
    2001
  • 负责人:
    Paul Barth Conrad
  • 依托单位: